MP Biomedicals announces the launch of advanced gastrointestinal diseases diagnostic kits

FHS
August 27, 2024
11:17 am

MP Biomedicals completes its range of in vitro diagnostic tests for infectious diseases with new immunochromatographic-based qualitative rapid tests.The new diagnostic kits by MP Biomedicals leverage cutting-edge technology to deliver precise results, enabling healthcare professionals a rapid and accurate detection of Helicobacter pylori, Salmonella typhi and Vibrio cholerae serogroups O1 and O139.

Lilly unveils more positive late-stage data for its once-weekly insulin

On Thursday, Eli Lilly dropped more data for its once-weekly insulin candidate in adults with type 2 diabetes. In two Phase 3 trials, dubbed QWINT

September 6, 2024

Clinicians at Legacy Health Move to Unionize

Physicians, physician assistants, and nurse practitioners from Oregon-based Legacy Health announced that they intend to unionize, following in the footsteps of other doctors from Legacy

May 15, 2024

Light-driven bacteria could be used to target and kill cancer cells

Targeting malignant tumors with high precision is challenging for biomedical researchers. However, this scenario is likely to witness a paradigm shift in the near future,

August 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.